Ok Hottuna, let's imagine for a second that both Teva and Mesoblast had access to the double blinded results that were less than positive, so my question is: Why would the Data Monitoring Committee allow the trial to continue and why would MSB choose to throw another $13million down the toilet?
MSB Price at posting:
$1.13 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)